Clinical, Social and Administrative Sciences, College of Pharmacy, Department of Health Management and Policy, The University of Michigan at Ann Arbor, 428 Church Street, Ann Arbor, MI 48109-1065, USA.
Indian J Med Res. 2013 Mar;137(3):494-501.
The need to focus healthcare expenditures on innovative and sustainable health systems that efficiently use existing effective therapies are the major drivers stimulating Comparative Effectiveness Research (CER) across the globe. Lack of adequate access and high cost of essential medicines and technologies in many countries increases morbidity and mortality and cost of care that forces people and families into poverty due to disability and out-of-pocket expenses. This review illustrates the potential of value-added global health care comparative effectiveness research in shaping health systems and health care delivery paradigms in the "global south". Enabling the development of effective CER systems globally paves the way for tangible local and regional definitions of equity in health care because CER fosters the sharing of critical assets, resources, skills, and capabilities and the development of collaborative of multi-sectorial frameworks to improve health outcomes and metrics globally.
需要将医疗支出集中在创新和可持续的医疗体系上,这些体系能够有效地利用现有的有效疗法,这是推动全球比较效果研究(CER)的主要动力。在许多国家,基本药物和技术的获取不足和成本高昂,导致发病率和死亡率上升,以及医疗费用增加,这使人们和家庭因残疾和自费而陷入贫困。本综述说明了增值型全球医疗保健比较效果研究在塑造“全球南方”的卫生系统和医疗服务提供模式方面的潜力。在全球范围内建立有效的 CER 系统为医疗保健公平性的具体本地和区域定义铺平了道路,因为 CER 促进了关键资产、资源、技能和能力的共享,以及多部门框架的合作发展,以改善全球的健康结果和指标。